The research, led by Xiaoyu Zhang, Kaiyun Fu, and colleagues at the Xinjiang Academy of Agricultural Sciences together with collaborators at the Chinese Academy of Sciences, focused on a class of regulatory molecules known as competing endogenous RNAs, or ceRNAs. The ceRNA hypothesis proposes that different RNA transcripts, including messenger RNAs that encode proteins as well as non-coding RNAs that do not, can communicate with one another by competing for the same microRNA molecules. MicroRNAs are short RNA fragments that bind to complementary sequences on target transcripts and suppress their activity. When a non-coding RNA sponges up a shared microRNA, it effectively shields other transcripts from repression, creating a regulatory network in which abundance of one RNA can indirectly control the expression of many others.

To map this network in a starving insect, the team performed whole-transcriptome sequencing on T. absoluta larvae under two conditions: larvae feeding on fresh tomato leaves and larvae subjected to starvation. By comparing the complete repertoire of expressed molecules between the two groups, they identified a striking number of differentially expressed transcripts. In total, the analysis revealed 46 differentially expressed microRNAs, 2,143 differentially expressed messenger RNAs, 391 differentially expressed long non-coding RNAs, and 1,635 differentially expressed circular RNAs. Circular RNAs, which are formed when RNA strands are joined head-to-tail into closed loops, are particularly stable molecules and have emerged as potent microRNA sponges in many organisms, making their large-scale differential expression especially noteworthy.

With these differential expression profiles in hand, the researchers constructed putative regulatory networks linking the different RNA classes. Using computational prediction of binding sites combined with expression correlation analyses, they built both lncRNA–miRNA–mRNA and circRNA–miRNA–mRNA interaction networks. These networks represent hypotheses about which non-coding RNAs might be titrating away which microRNAs, and consequently which protein-coding genes might be released from repression or placed under additional control during starvation. The scale of the networks suggests that ceRNA-mediated crosstalk is a substantial component of the leafminer’s stress response rather than a marginal curiosity.

Functional enrichment analysis of the genes embedded in these networks provided the first clues about what the regulation is actually accomplishing. The differentially expressed messenger RNAs, the predicted microRNA target genes, and the host genes that give rise to circular RNAs were predominantly associated with chitin metabolism, lipid catabolism, fatty acid biosynthesis, and detoxification pathways. Each of these categories makes biological sense for a starving insect. Chitin is the structural polymer of the insect cuticle and gut lining, and its remodeling may reflect the physiological strain of fasting. Lipid catabolism and fatty acid metabolism are the classic fallback energy pathways when dietary carbohydrates and proteins run out, allowing the animal to mobilize stored fat reserves. Detoxification pathways, meanwhile, may help the insect cope with the metabolic byproducts of starvation or maintain its chemical defenses.

Deeper pathway analysis using the Kyoto Encyclopedia of Genes and Genomes reinforced this metabolic picture. Significant enrichment was observed in AMPK signaling, a conserved cellular energy-sensing pathway that switches on when intracellular energy levels fall and orchestrates the shift from energy consumption to energy production. Insulin signaling was also enriched, reflecting its central role in coordinating growth, nutrient storage, and mobilization in response to nutritional state. The biosynthesis of unsaturated fatty acids appeared as another significantly enriched pathway, consistent with the idea that starving larvae adjust the composition of their membrane lipids and fuel reserves to survive the crisis. Together, these pathways sketch a coherent strategy: sense the energy deficit, reroute metabolism toward stored fats, and adjust cellular infrastructure accordingly.

Perhaps the most striking single finding is the identification of two microRNAs, miR-6497a and miR-6498-5p, as putative key regulatory hubs within the ceRNA network. These two microRNAs were predicted to interact with multiple differentially expressed long non-coding RNAs, circular RNAs, and messenger RNAs simultaneously, placing them at the center of a dense web of potential crosstalk. In the ceRNA framework, a hub microRNA whose binding is contested by many sponges can exert broad, condition-dependent control over entire functional modules. If experimental work confirms these interactions, miR-6497a and miR-6498-5p would represent master switches that help determine how the leafminer’s metabolism is reconfigured when food disappears.

The study’s significance extends well beyond basic biology. Tuta absoluta, native to South America, has spread rapidly across Europe, Africa, and Asia since its initial invasions and remains a persistent threat to tomato production worldwide. Its capacity to survive unfavorable conditions, including gaps in food availability between crops or during dispersal, contributes to its invasive success and complicates control efforts. Current management relies heavily on chemical insecticides, against which the species has already evolved resistance to multiple modes of action. This has intensified interest in RNA interference as an alternative: double-stranded RNA molecules can be designed to silence essential pest genes with high specificity, and several RNAi-based products are in development for agricultural use. The ceRNA networks described in this study offer a catalog of candidate targets, particularly the hub microRNAs and the non-coding RNAs that regulate them, whose disruption could impair the pest’s ability to withstand starvation and other stresses encountered in the field.

The work also adds to a growing appreciation that non-coding RNAs are not background noise but active participants in how organisms respond to their environments. Long non-coding RNAs and circular RNAs have been implicated in stress responses in many species, but their roles in agricultural insect pests remain poorly charted. By integrating all four major RNA classes in a single analysis, the researchers demonstrated a methodology that other pest biologists can replicate, connecting transcriptome-wide discovery with functional interpretation. The authors caution that the networks are putative, resting on computational prediction and expression correlation, and that experimental validation will be needed to confirm individual interactions and to test whether manipulating these RNAs genuinely compromises the insect’s stress tolerance.

Even so, the study marks an important step in the molecular dissection of one of agriculture’s most notorious adversaries. It shows that when the tomato leafminer goes hungry, it does not simply slow down; it activates a coordinated, multi-layered RNA regulatory program that touches energy sensing, fat metabolism, structural remodeling, and detoxification all at once. Understanding that program in detail, and learning to break it, could give crop scientists a much-needed new angle of attack against a pest that has repeatedly outmaneuvered conventional control methods. For now, the humble non-coding RNA molecules once dismissed as transcriptional clutter have emerged as promising new players in the ongoing arms race between farmers and the insects that threaten their harvests.

Subject of Research: ceRNA regulatory networks in Tuta absoluta adaptation to starvation stress

Article Title: Integrated whole‑transcriptome analysis reveals ceRNA regulatory networks underlying Tuta absoluta (Meyrick) (Lepidoptera: Gelechiidae) adaptation to starvation stress

Article References: Zhang, X., Wen, Y., Jia, Z., Wang, X., Wu, J., Ding, X., Guo, W., & Fu, K. (2026). Integrated whole‑transcriptome analysis reveals ceRNA regulatory networks underlying Tuta absoluta (Meyrick) (Lepidoptera: Gelechiidae) adaptation to starvation stress. BMC Genomics. https://doi.org/10.1186/s12864-026-13273-x

Image Credits: AI Generated

DOI: 10.1186/s12864-026-13273-x

Keywords: Tuta absoluta, tomato leafminer, ceRNA, non-coding RNAs, microRNAs, lncRNAs, circRNAs, starvation stress, transcriptomics, AMPK signaling, lipid metabolism, RNAi pest control

Dyslipidemia, the medical term for an unhealthy balance of fats circulating in the blood, is one of the most common metabolic disturbances in the modern world. When total cholesterol and low-density lipoprotein cholesterol, often called LDL or the atherogenic form of cholesterol, climb too high, fatty deposits accumulate along arterial walls, stiffening vessels and setting the stage for heart attacks and strokes. Oxidative stress compounds the problem. In metabolically stressed tissue, cells generate an excess of reactive oxygen species, chemically aggressive molecules that attack lipids, proteins, and DNA. In the liver, this oxidative assault drives lipid peroxidation, the chain-reaction degradation of fats that damages hepatic cells and worsens the lipid imbalance. The two processes feed each other, which is why interventions that address both simultaneously are of particular interest to nutritional scientists.

The research team, led by Mei Tong He and Yu Ri Jeong of Gyeongsang National University together with colleagues at the National Institute of Forest Science, set out to test whether honey derived specifically from Hedera rhombea flowers could intervene in this vicious cycle. The researchers chose this honey partly because of its botanical origin: ivy plants are known to contain a rich array of bioactive phenolic compounds, and prior work has shown that chemical constituents isolated from Hedera rhombea fruits exhibit inhibitory activity against enzymes linked to metabolic disease. Because bees concentrate plant-derived phytochemicals in their honey, the team hypothesized that an ivy floral source might yield a product with unusually strong metabolic and antioxidant properties.

To test the hypothesis, the researchers induced dyslipidemia in mice by placing them on a high-fat diet, a well-established model that reliably reproduces the elevated cholesterol, elevated LDL, and elevated atherogenic index seen in human metabolic syndrome. The atherogenic index, a calculated ratio derived from blood lipid measurements, serves as a composite predictor of cardiovascular risk. Mice in the treatment groups received Hedera rhombea honey at doses of 0.5 and 1 gram per kilogram of body weight per day over a four-week period. This dosing regimen allowed the team to evaluate both the efficacy and any dose-dependence of the honey’s effects.

The results on lipid metabolism were striking. Compared with untreated mice on the high-fat diet, the honey-supplemented animals showed significantly lower total cholesterol, significantly lower LDL cholesterol, and a significantly reduced atherogenic index. In practical terms, the honey appeared to blunt the lipid-raising consequences of an obesogenic diet rather than merely shifting numbers at the margins. Because circulating cholesterol is largely managed by the liver, which packages, exports, and clears lipoproteins, the authors turned their attention to hepatic tissue to understand where the intervention was acting.

What they found in the liver pointed to a coordinated rescue of the organ’s antioxidant defense system. Mice receiving the honey exhibited markedly reduced lipid peroxidation, indicating that their fat molecules were undergoing less oxidative degradation. Levels of nitric oxide and reactive oxygen species in hepatic tissue also fell, while the expression of antioxidant-related genes and the activity of antioxidant enzymes rose. Perhaps most tellingly, the treatment increased levels of phosphorylated AMPK, or p-AMPK, in the liver. AMP-activated protein kinase is a master metabolic sensor that, when activated, shifts cellular metabolism away from energy storage and toward energy burning, promoting fatty acid oxidation and suppressing cholesterol synthesis. Upregulation of AMPK signaling is a recognized mechanism through which natural products counteract non-alcoholic fatty liver disease and related disorders, and its activation here suggests that the honey’s benefits operate through a well-characterized regulatory pathway rather than an incidental effect.

Beyond cholesterol, the study probed markers of thrombosis, the formation of blood clots that transforms arterial plaques into life-threatening events. High-fat feeding is known to disturb hemostasis, elevating factors that promote both platelet activation and coagulation. In the treated mice, serum levels of thromboxane B2, a stable metabolite that reflects platelet activation, and coagulation factor VII, a key protein in the clotting cascade, were both significantly reduced. This observation is notable because it extends the honey’s apparent benefits beyond lipid chemistry into the domain of blood rheology, echoing earlier human and animal studies suggesting that natural honey consumption can influence platelet function and coagulation proteins. Lowered thrombogenic potential, combined with improved lipids, paints a broader picture of cardiovascular protection than either measure alone.

To explore whether the honey could also protect blood vessels directly, the team turned to an in vitro model using human umbilical vein endothelial cells, or HUVECs, the workhorse cell type for studying vascular biology. These cells were stimulated with tumor necrosis factor-alpha, an inflammatory signaling molecule abundant in obesity and metabolic disease that provokes endothelial cells to produce intracellular reactive oxygen species and express adhesion molecules that recruit immune cells to the vessel wall. When the researchers pretreated the cells with the ivy honey, the TNF-alpha-induced surge of intracellular ROS was significantly and dose-dependently reduced. Because endothelial dysfunction driven by oxidative stress is considered an initiating event in atherosclerosis, this cellular result complements the animal data and suggests a plausible mechanism by which the honey’s constituents might shield the vascular lining.

The convergence of results across three levels, whole-animal lipid profiles, hepatic molecular signaling, and cultured human vascular cells, strengthens the study’s central claim: that honey from Hedera rhombea acts by regulating lipid metabolism, bolstering antioxidant defenses, and engaging AMPK signaling simultaneously. The authors conclude that the honey may serve as a promising functional food ingredient for improving dyslipidemia and oxidative stress. The work was supported by the National Institute of Forest Science in Korea, reflecting a broader national interest in identifying value-added products from forest-derived resources, and the study builds on earlier research in which the same honey was explored as a sugar substitute in functional cookies designed to slow carbohydrate digestion.

As with any preclinical study, caution is warranted before extrapolating to the breakfast table. The mice received controlled doses over a defined period, and the doses used, translated to human scales, would represent meaningful daily quantities of honey with corresponding caloric load. Human clinical trials with natural honeys have produced mixed but often encouraging results on lipid profiles, and systematic reviews have suggested potential benefits of honey in obesity management, yet floral source, regional composition, and phenolic content vary enormously between honeys, making it hazardous to generalize from one botanical variety to another. Indeed, the fact that this study focused on a single, carefully characterized floral source may be its greatest strength, since honey’s biological activity is increasingly understood to depend on the specific phenolic compounds imparted by its nectar origin. If future studies confirm these effects in humans and identify the responsible compounds, ivy honey could join the growing roster of bee products under serious investigation not as folk remedies but as chemically characterized functional foods with measurable metabolic effects. For now, the study offers an intriguing glimpse of how a traditional food, harvested from an unassuming climbing vine, might one day earn a place in evidence-based strategies against the world’s most burdensome chronic diseases.

Subject of Research: Effects of honey from Hedera rhombea Bean on dyslipidemia and oxidative stress in high-fat diet-induced mice

Article Title: Effects of honey from Hedera rhombea Bean on dyslipidemia and oxidative stress in high-fat diet-induced mice

Article References: He, M. T., Jeong, Y. R., Kim, G. M., Lee, A. Y., Na, S.-J., Kim, H.-J., & Kim, J. H. (2026). Effects of honey from Hedera rhombea Bean on dyslipidemia and oxidative stress in high-fat diet-induced mice. Food Science and Biotechnology. https://doi.org/10.1007/s10068-026-02313-7

Image Credits: AI Generated

DOI: 10.1007/s10068-026-02313-7

Keywords: Hedera rhombea, honey, dyslipidemia, oxidative stress, high-fat diet, AMPK signaling, lipid metabolism, reactive oxygen species, HUVECs, atherogenic index, antioxidant enzymes, functional food

Obesity arises from a complex interplay of genetic predisposition, environmental pressures, and lifestyle factors, culminating in the abnormal accumulation of adipose tissue. At the cellular level, the expansion of fat mass depends on adipogenesis, the process by which precursor cells differentiate into mature adipocytes that store lipid. Interrupting this process has long been a strategic goal for metabolic research, and natural products have increasingly been scrutinized as sources of candidate anti-adipogenic molecules. Glycyrrhiza uralensis, known in traditional medicine for its anti-inflammatory and antioxidant properties, had previously been linked to metabolic effects, but gancaonin N itself had never been examined for its potential to modulate fat cell formation and lipid metabolism.

To close that gap, the research team deployed a two-pronged strategy. First, they used network pharmacology, a computational framework that maps the interactions between bioactive compounds, their molecular targets, and disease-associated genes. By predicting the targets of gancaonin N and intersecting them with genes linked to obesity, the team identified 17 overlapping targets. Enrichment analyses using the Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes pointed toward pathways governing lipid metabolism, adipocyte differentiation, and AMP-activated protein kinase signaling, a central energy-sensing cascade within cells.

Central to these computational predictions were two hub genes with well-documented roles in fat biology: peroxisome proliferator-activated receptor gamma, often described as the master transcriptional regulator of adipocyte differentiation, and fatty acid synthase, the enzyme responsible for de novo lipid synthesis. The network analysis suggested that gancaonin N might act on precisely the molecular machinery that drives cells toward the fat-storing phenotype, setting the stage for laboratory confirmation.

For the experimental phase, the researchers turned to 3T3-L1 preadipocytes, mouse cells that can be reliably driven to differentiate into mature adipocytes using a hormonal cocktail that includes 3-isobutyl-1-methylxanthine, dexamethasone, and insulin, a protocol abbreviated as MDI. This model is a cornerstone of adipogenesis research because it recapitulates, with remarkable fidelity, the transcriptional and morphological changes that accompany fat cell development in living tissue. When the team treated differentiating cells with gancaonin N, the results were striking.

Oil Red O staining, the classic technique that renders accumulated lipid droplets a vivid red, revealed that adipocyte differentiation and lipid accumulation were significantly inhibited in a concentration-dependent manner. In other words, the more gancaonin N the cells received, the less fat they stored. The suppression was not merely cosmetic: molecular analyses at both the protein and messenger RNA levels confirmed a coordinated shutdown of the adipogenic program.

Western blotting and PCR analyses showed downregulation of the key transcription factors that orchestrate adipocyte identity, including PPARγ, CCAAT/enhancer-binding protein alpha, and sterol regulatory element-binding protein 1c. These regulators function as a hierarchical circuit: C/EBPα and PPARγ reinforce each other’s expression to lock cells into the adipocyte fate, while SREBP-1c drives the expression of lipogenic enzymes. Their coordinated suppression indicates that gancaonin N intervenes early and broadly in the differentiation cascade rather than acting on a single downstream node.

The compound also suppressed lipogenic genes such as fatty acid synthase and fatty acid binding protein 4, or FABP4, proteins that equip mature adipocytes to synthesize and store lipid. Perhaps most intriguingly, gancaonin N was associated with activation of AMP-activated protein kinase, a cellular energy sensor that, when switched on, shifts metabolism away from synthesis and storage and toward fatty acid oxidation and energy expenditure. AMPK activation is a mechanism shared by several established metabolic interventions, including exercise and the diabetes drug metformin, which lends mechanistic plausibility to the observed anti-adipogenic effects.

The study’s integrated design deserves attention in its own right. By using network pharmacology to generate hypotheses and then validating them in a controlled cellular system, the researchers demonstrated a workflow that can efficiently triage natural compounds for metabolic activity, potentially accelerating the discovery of anti-obesity agents from the vast repository of traditional medicine. The authors emphasize that gancaonin N appears to regulate adipocyte differentiation and lipid metabolism through multiple signaling pathways simultaneously, a multi-target profile that distinguishes it from single-node approaches.

Important caveats remain. The evidence is confined to a cell culture model, and the journey from inhibited lipid droplets in a petri dish to a clinically meaningful effect on human body weight is long and uncertain, requiring studies in animal models and, eventually, controlled human trials to establish efficacy, bioavailability, and safety. Nevertheless, the identification of a licorice-derived isoflavone that converges on PPARγ, SREBP-1c, and AMPK, three of the most consequential nodes in metabolic regulation, provides a compelling molecular foundation for further exploration. As obesity rates continue to climb globally, compounds like gancaonin N illustrate how ancient pharmacopeias may still yield modern therapeutic insights when subjected to the scrutiny of contemporary molecular science.

The choice of gancaonin N as a study subject reflects a broader trend in pharmacognosy, the discipline that investigates medicines derived from natural sources. Licorice root contains hundreds of structurally diverse secondary metabolites, including glycyrrhizin, flavonoids, chalcones, and isoflavones, many of which carry prenyl side chains. Prenylation, the attachment of a hydrophobic isoprenoid group to a flavonoid scaffold, generally increases a molecule’s lipophilicity and can enhance its affinity for cellular membranes and intracellular protein targets. This structural feature may help explain why prenylated isoflavones from licorice have repeatedly attracted attention in studies of inflammation, cancer biology, and now energy metabolism, since improved membrane permeability can translate into more pronounced activity in cultured cells.

The network pharmacology approach used by the team deserves further explanation for readers unfamiliar with the method. Rather than testing a compound against one presumed target at a time, network pharmacology treats drug action as a web of interactions. Researchers first compile a list of proteins predicted to bind the compound, drawing on databases of known drug-target relationships and structural similarity. They then overlay this list with genes statistically associated with a disease, in this case obesity, and examine where the two sets intersect. The resulting overlap, here 17 shared targets, is subjected to enrichment analysis to determine which biological processes and signaling pathways are overrepresented. This systems-level view acknowledges that most chronic diseases involve dozens of interacting pathways, and that multi-target interventions may better reflect how traditional herbal medicines have historically been understood to act.

The molecular findings also fit into a well-mapped hierarchy of fat cell biology. PPARγ sits at the apex of the adipogenic transcriptional cascade, and its activity is sufficient to drive even non-fat cells toward lipid storage, which is why it has been the target of thiazolidinedione diabetes drugs. Downstream of these transcription factors, FABP4 serves as a cytoplasmic chaperone for fatty acids and is widely used as a marker of mature adipocyte function. Upstream, AMPK acts as a fuel gauge: when cellular energy levels fall, AMPK phosphorylates downstream targets such as acetyl-CoA carboxylase, thereby throttling fatty acid synthesis and promoting oxidation. The observation that gancaonin N both suppresses pro-adipogenic transcription factors and engages this energy-sensing pathway suggests a coordinated mechanism rather than a single point of interference.

The 3T3-L1 model itself has a long pedigree. Derived from mouse embryos in the 1970s, these cells have been used in thousands of studies precisely because their differentiation is robust, reproducible, and amenable to quantitative readouts such as Oil Red O extraction and spectrophotometric measurement. Findings in this system, however, do not automatically translate to human physiology. Human adipocytes differ in gene expression patterns, receptor repertoires, and metabolic flux, and the concentrations of a compound that are achievable in culture medium often far exceed what can be reached in circulating blood after oral ingestion. Absorption, metabolism by liver enzymes, and rapid excretion can all diminish the effective exposure of tissues to a dietary flavonoid.

These considerations frame the appropriate next steps. Animal studies using diet-induced obesity models would test whether gancaonin N or licorice extracts enriched in it can influence weight gain, insulin sensitivity, and adipose tissue morphology in a living organism. Pharmacokinetic profiling would establish whether meaningful plasma concentrations are attainable and whether the compound accumulates in adipose tissue. Safety evaluation is equally essential, since licorice is known to contain constituents with documented physiological effects, and any candidate derived from this plant would need to demonstrate a favorable therapeutic window.

The research was conducted by investigators affiliated with the College of Korean Medicine at Kyung Hee University in Seoul, together with collaborators at the Korea Institute of Science and Technology, and was supported by funding from the Korea Health Industry Development Institute under the Ministry of Health and Welfare of the Republic of Korea. The work was published as an open access article under a Creative Commons Attribution license, received in October 2025 and accepted in August 2026, allowing the scientific community unrestricted access to the methods and data. As with all early-stage findings, the value of this study lies less in immediate application than in the hypothesis it generates: that a defined molecule from a traditional medicinal plant can be traced, target by target, through the molecular circuitry of fat cell formation.

Subject of Research: Anti-adipogenic effects of the licorice-derived compound gancaonin N on adipocyte differentiation and lipid metabolism in 3T3-L1 cells

Article Title: Anti-adipogenic effects of gancaonin N, a bioactive compound from Glycyrrhiza uralensis, in MDI-Induced 3T3-L1 adipocytes

Article References: Kim, S. W., Kwon, S., Jee, W., Kim, N., Kim, M., Byun, D. Y., Kwon, S., Lee, H.-G., Chung, W.-S., & Jang, H.-J. (2026). Anti-adipogenic effects of gancaonin N, a bioactive compound from Glycyrrhiza uralensis, in MDI-Induced 3T3-L1 adipocytes. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05566-1

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05566-1

Keywords: gancaonin N, Glycyrrhiza uralensis, adipogenesis, obesity, lipid metabolism, AMPK signaling, PPARγ, 3T3-L1 adipocytes, network pharmacology, licorice, fatty acid synthase, natural products